NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19

Niaid.nih.gov

Click here to subscribe to Niaid.nih.gov

4 years ago

Html
Text

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19 09/10/2020 03:00 PM EDT
The trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Share on

Other newsletters from Niaid.nih.gov

Register to Join! NIH World AIDS Day Event Niaid.nih.gov
6 hours ago
Regstrese para unirse! Evento d el Da Mundial del SIDA de los NIH Niaid.nih.gov
6 hours ago
Newer epilepsy medications used during pregnancy do not affect neurological development in children Niaid.nih.gov
10 hours ago

More newsletters from Niaid.nih.gov

NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19

Share on

Other newsletters from Niaid.nih.gov

Related newsletters